Molecular Biology Study Guide: Replication, Telomeres, and Transcription

Fundamentals of DNA Replication and Key Enzymes

• DNA replication occurs in a semi-discontinuous manner across the double helix:

  • Leading Strand: Synthesized continuously all at once in the $5' \rightarrow 3'$ direction.

  • Lagging Strand: Synthesized discontinuously in short segments (Okazaki fragments) in the $3' \rightarrow 5'$ directional orientation relative to the template strand (with synthesis occurring $5' \rightarrow 3'$).

  • Mechanism Requirement: DNA polymerase, the enzyme responsible for synthesizing new DNA strands using template strands, can only append free nucleotides to the $3'-OH$ end of an existing polynucleotide chain.

• Initiation and Unwinding:

  • Helicase enzyme attaches to the double helix and breaks hydrogen bonds to unwind the two strands, exposing single-stranded DNA templates.

  • Replication Fork: The Y-shaped point at which the two strands are actively separated.

• RNA Priming:

  • Primase enzyme attaches to each template DNA strand.

  • Primase synthesizes a short RNA primer complementary to the template in the $5' \rightarrow 3'$ direction.

  • Once the RNA primer reaches a specific length, primase detaches from the template strand.

• Elongation:

  • A DNA polymerase molecule attaches to each template strand at the $3'$ end of the newly formed RNA primer.

  • DNA polymerase extends the primer by adding complementary DNA nucleotides in the $5' \rightarrow 3'$ direction.

  • On the leading strand template, DNA polymerase continuously synthesizes new DNA moving toward the opening replication fork.

  • On the lagging strand template, DNA polymerase moves away from the opening replication fork as it synthesizes in the $5' \rightarrow 3'$ direction.

• Lagging Strand Assembly and Fragment Ligation:

  • Because the fork continues opening behind the polymerase on the lagging strand, primase must repeatedly attach to synthesize new RNA primers near the fork.

  • DNA polymerase initiates synthesis at each new primer, generating a series of short segments called Okazaki fragments.

  • To create a continuous strand, a different DNA polymerase recognizes and excises the RNA primers, replacing them with DNA nucleotides.

  • The DNA Nick: Polymerase cannot form the final phosphodiester bond between the $3'-OH$ end of one fragment and the $5'-phosphate$ end of the adjacent fragment, leaving a structural gap known as a nick.

  • DNA Ligase: The enzyme DNA ligase catalyzes the missing bond to seal the nick and produce a contiguous DNA strand.

Cell Cycle Phases, Okazaki Fragments, and Single-Stranded Binding Proteins

• Historical Context of Cell Cycle Naming:

  • The "G" in $G_1$ and $G_2$ stands for "gap".

  • Early light microscopy permitted visualization of condensed chromosomes only during active mitosis ($M$ phase: prophase, metaphase, anaphase, telophase).

  • Interphase non-dividing states (such as differentiated kidney cells performing normal physiology) appeared as inactive gaps under early microscopes.

• Okazaki Fragment Phase Specificity:

  • If cells in $G_1$, $G_0$, $G_2$, or active mitosis ($M$ phase) are lysed and heated in warm water, no Okazaki fragments are observed.

  • Okazaki fragments appear exclusively when cells in the $S$ phase (synthesis phase) are lysed and heated, yielding short single-stranded DNA fragments.

• Single-Stranded Binding Proteins (SSBs):

  • Environmental conditions trigger the expression of genes encoding single-stranded binding proteins.

  • Genes are transcribed to RNA and translated into SSB proteins, which immediately bind single-stranded DNA exposed at the replication fork to prevent premature re-annealing or enzymatic degradation.

• Termination of Replication:

  • Continuous leading strand synthesis and discontinuous lagging strand synthesis proceed until the replication fork meets an adjacent replication fork traveling in the opposite direction or reaches the physical end of the chromosome.

Telomeres, End-Replication Problem, and Accumulation of Errors

• RNA Primer Degradation and Instability:

  • Multiple RNA primers generated along the lagging strand must be removed.

  • Eukaryotic RNA is chemically unstable due to the reactive $2'-OH$ group on its ribose sugar.

  • Cellular RNA typically exhibits a half-life of seconds to minutes (rarely lasting 1 to 2 hours) before degrading.

  • When primers at the extreme terminal ends of linear chromosomes degrade, DNA polymerase cannot replace them due to the absence of a upstream $3'-OH$ primer end.

• Telomere Shortening:

  • Terminal primer degradation leaves single-stranded overhangs that are chewed back by cellular nucleases, progressively shortening the chromosome with each round of division.

  • Aglet Analogy: Telomeres act like aglets (the plastic tips at the end of shoelaces) by capping and protecting chromosome ends against degradation, though unlike aglets, telomeres shorten over time.

• Mutation Accumulation Model:

  • Uncorrected replication errors become permanent template mutations in subsequent replication rounds.

  • Example Sequence: A chromosome copied with 2 initial errors will transmit those 2 permanent errors; subsequent copy rounds may add 3 new errors (totaling 5), and the following round may yield 9 cumulative errors.

  • DNA replication errors accumulate exponentially over progressive cell generations, akin to duplicating a photocopy containing typos.

Telomerase Enzyme: Structure, Function, and Biological Roles

• Structure and Enzymatic Mechanism of Telomerase:

  • Telomerase is a ribonucleoprotein complex consisting of a reverse transcriptase protein and an internal RNA molecule.

  • The internal RNA template contains a specific short repetitive stretch (including sequences complementary to telomeric repeats, such as $AAU$ sequences).

  • Extension Process:

  1. Telomerase binds specifically to the exposed $3'$ single-stranded DNA overhang at the chromosome terminus.

  2. Using its internal RNA template, telomerase adds repetitive DNA sequence units (e.g., $T-A-A-G-A-G$) directly to the $3'$ end of the DNA strand.

  3. Telomerase translocates along the newly extended strand, re-binds, and synthesizes additional repeats.

  4. Once the $3'$ overhang is sufficiently extended, primase attaches to synthesize an RNA primer, enabling DNA polymerase to synthesize the complementary lagging strand.

• Biological Roles and Tissue Expression:

  • Junk DNA Context: Telomeric repeats account for only a tiny fraction of total non-coding ("junk") genomic DNA.

  • Embryonic Development: Following fertilization, a single zygote cell must replicate into approximately $7 \times 10^{12}$ to $60 \times 10^{12}$ cells to form a human fetus, requiring active telomerase to bypass standard division limits.

  • Stem Cells: Stem cell lineages retain high telomerase expression to sustain self-renewal and continually produce gametes (sperm and egg cells).

  • Immune System Activation: Clonal expansion of antigen-specific B cells during an infection requires rapid proliferation from a few original cells into millions of lymphocytes, necessitating temporary telomerase up-regulation.

  • Adult Somatic Tissues: Telomerase is normally turned off (down-regulated) in most differentiated somatic tissues to enforce cell division limits and prevent tumorigenesis.

Senescence, Replicative Limits, and the Hayflick Limit

• The Hayflick Limit:

  • Somatic cells can undergo approximately 50 to 60 (or 60 to 70) cell divisions before telomeres erode to a critical threshold.

  • Named after the scientist who discovered this finite cellular division ceiling.

• DNA Damage Response and Senescence Triggering:

  • When telomeres become critically shortened, internal cell signals trigger a DNA damage response.

  • The cell halts replication permanently to prevent critical coding DNA from being damaged or mutated in subsequent divisions.

  • Senescent State: Cells undergo morphological, transcriptomic, and functional alterations. While senescent cells remain metabolically active and contribute to basic tissue architecture, they are rendered entirely incapable of division.

  • Causes of Senescence: Critical telomere shortening (replicative senescence), dysfunctional telomere capping proteins, direct genomic mutations, or toxic oxidative DNA damage.

• Physiological Impact of Senescent Cells:

  • Protective Effect: Senescence acts as a primary tumor suppressor mechanism by stopping damaged cells from proliferating into cancers.

  • Pathological Effect: As tissues age, senescent cells accumulate in organs (e.g., liver, lungs, skin). Because senescent cells possess diminished physiological function and cannot replicate, overall organ tissue repair capacity declines, contributing to age-related pathologies such as cataracts.

Cellular Categories: Mitotic vs. Post-Mitotic Cells

• Mitotic Cells:

  • Tissues composed of cells capable of undergoing active mitosis to replenish and regenerate tissue structures.

  • Examples: Skin epithelial cells, fibroblast cells forming organ scaffolding (e.g., kidney, liver), endothelial cells lining blood vessels, and tissue stem cells.

  • Senescence Path: Susceptible to replicative senescence via the Hayflick limit as telomeres shorten across successive doublings.

• Post-Mitotic Cells:

  • Terminally differentiated cells incapable of proliferation or mitotic division.

  • Examples: Neurons in the central and peripheral nervous system, mature cardiac muscle cells (cardiomyocytes).

  • Regeneration: Tissue regeneration occurs extremely slowly and depends entirely on rare tissue-specific stem cells.

  • Senescence Path: Incapable of replicative senescence (due to absence of replication), but can be induced directly into a senescent state by environmental toxins or uncorrected DNA damage.

• Cell Division Capacity vs. Doublings Curve:

  • Somatic Mitotic Cells: Start with high division capacity; capacity curves steadily downward toward zero as the number of cell doublings increases due to progressive telomere loss.

  • Stem Cells: Start with high division capacity; curve remains indefinitely high and flat across doublings due to constitutive telomerase expression restoring telomere length.

  • Cancer Cells: Somatic cells that acquire mutations reactivating telomerase escape the somatic decay curve, bypass senescence, and maintain infinite proliferative capacity.

Case Study: Henrietta Lacks and HeLa Cells

• Patient History and Cell Line Isolation:

  • In 1946, Henrietta Lacks, a Black woman from a low-income family, sought medical care for cervical cancer at Johns Hopkins Hospital.

  • During a Pap smear/biopsy procedure, tissue samples were harvested without her knowledge, consent, or signed waiver (a standard practice at the time).

• Molecular Characteristics of HeLa Cells:

  • The tumor cells exhibited constant, aberrant up-regulation of the telomerase enzyme.

  • Telomeres in these cells never shortened during division, completely bypassing the Hayflick limit and avoiding senescence.

  • This yielded the first immortal human cell line, capable of dividing indefinitely in culture.

• Ethical and Commercial Implications:

  • Henrietta Lacks died shortly after her diagnosis.

  • Her immortalized cells (HeLa cells) were patented and commercialized by major pharmaceutical entities, generating billions of dollars in global revenue.

  • Neither Henrietta Lacks nor her family received financial compensation or early acknowledgment for the immense biomedical contributions of HeLa cells.

Cancer Therapeutics, Micro-Interfering RNA, and Delivery Challenges

• Telomerase Inhibition as Cancer Therapy:

  • Because ~90% of human tumors up-regulate telomerase to escape senescence, inhibiting telomerase presents a strategy to force cancer cells into senescence or apoptosis.

• Micro-Interference RNA (miRNA/siRNA):

  • Small interfering RNA molecules can be designed to target and degrade telomerase mRNA transcripts, knocking down enzyme activity.

• In Vivo Delivery Barrier:

  • A primary challenge in clinical oncology is drug delivery throughout solid tumor masses.

  • Systemic administration of miRNA therapeutics often successfully enters only ~2% of tumor cells in human tissue, leaving the remaining tumor mass free to proliferate.

Course Logistics and Homework Guidelines

• Assignment Deadlines:

  • Homework assignments are due exactly one week following the completion of the respective chapter in lecture.

  • Chapter 2 Homework: Due Tuesday night.

  • Chapter 3 Homework: Due Thursday night.

  • Junk DNA Quizzes: Due every Sunday night.

  • No extensions are granted for missed assignments.

• Study Resources and Time Constraints:

  • Relevant practice questions listed in the course syllabus are located at the back of textbook chapters (book available on reserve in the university library).

  • Online homework allows an average time allocation of 2 minutes per multiple-choice question.

Transcription, RNA Characteristics, and Functional RNA Types

• Cell Cycle Context:

  • Transcription occurs during the $G_1$ and $G_2$ gap phases of the cell cycle, distinct from the $S$ phase (DNA replication).

• Chemical Properties of RNA:

  • Synthesized using a DNA template strand in the $5' \rightarrow 3'$ direction.

  • Ribose sugars in RNA possess both a $2'-OH$ group and a $3'-OH$ group.

  • Phosphodiester bond formation requires the free $3'-OH$ group to attach incoming ribonucleotides.

• Functional Categories of RNA:

  • Messenger RNA (mRNA): Protein-coding transcripts; length ranges from a few hundred to thousands of nucleotides.

  • Transfer RNA (tRNA): Delivers specific amino acids to the ribosome during translation.

  • Ribosomal RNA (rRNA): Structural and catalytic core of ribosomes; visible under microscopy as dense granules coating the rough endoplasmic reticulum.

  • MicroRNA (miRNA / Small Regulatory RNA):

  • Originally discovered in Caenorhabditis elegans (nematode worms); initially dismissed as non-functional "junk DNA".

  • Ubiquitous in eukaryotes and critical for post-transcriptional gene regulation and human disease control.

  • Small Nuclear RNA (snRNA):

  • Small, tube-like RNA molecules confined strictly to the cell nucleus (never exported to the cytoplasm).

  • Functions as the essential catalytic machinery for eukaryotic pre-mRNA splicing and processing (a process absent in prokaryotes).

Gene Structure, Codons, Promoters, and Regulatory Elements

• Essential Codons for Examination:

  • Start Codon: $AUG$

  • Stop Codons: $UAA$, $UAG$, $UGA$

  • Note: Codon lookup tables are provided for all other amino acids during examinations.

• Transcription Template Asymmetry:

  • RNA is single-stranded.

  • Specific RNA molecules are transcribed using one strand of DNA as a template, while other RNA molecules are transcribed from the complementary DNA strand.

• Promoter Architecture:

  • A promoter is a specific non-coding DNA sequence upstream of a gene that defines the transcription start site.

  • TATA Box: Conserved sequence positioned near $-25$ to $-30$ base pairs relative to the initiation site.

  • CAAT Box: Conserved regulatory sequence positioned around $-75$ base pairs (informally referred to in laboratory settings as the "litter box").

  • $-90$ GC Box: A GC-rich sequence centered near $-90$ base pairs upstream.

• Site-Directed Mutagenesis Studies:

  • Targeted genetic modification techniques allow researchers to alter a single specific base out of $3.5 \times 10^9$ base pairs in the human genome (e.g., base position 365).

  • Mutating key promoter consensus sequences (e.g., changing a G/C base to a C) severely reduces or completely eliminates gene transcription.

• Distal Enhancer Elements:

  • Gene expression is also regulated by enhancer sequences located tens of thousands of base pairs away, separated from the promoter by 20 to 30 intervening genes.